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Juan Sendon-Lago1, Samuel Seoane1, Noemi Eiro2, Maria A. Bermudez1, Manuel Macia3, Tomas Garcia-Caballero4,
Francisco J. Vizoso2 and Roman Perez-Fernandez1*Erratum
After the publication of this work [1] an error was noticed
in Fig. 4d and 4f. In the migration and invasion assays the
same image was used accidentally for the Pit-1 + shMMP-
1 and Pit-1 + shMMP-13. The corrected figure is shown
below. The error does not affect the findings or conclu-
sion of the article. We apologize for this error.
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Fig. 4 MMP-1 and MMP-13 knockdown reduces invasive features in MCF-7 cells with Pit-1 overexpression, and in MDA-MB-231 cells. a-b Wound-
healing assay in (a) MCF-7 cells with Pit-1 overexpression (pRSV-hPit-1), and knockdown of MMP-1 (shMMP-1(1) and shMMP-1(2)) and MMP-13
(shMMP-13(1) and shMMP-13(2)); (B) MDA-MB-231 cells with knockdown of Pit-1 (siPit-1), MMP-1 (shMMP-1(1) and shMMP-1(2)), and MMP-13 (shMMP-
13(1) and shMMP-13(2)). Distance between the wound edges was measured at 48 hours in three different assays, and data are represented as mean ±
SD; ns = not significant. c-d Cell motility through uncoated filters (migration) at 24 hours in control MCF-7 cells (pRcRSV), Pit-1-overexpressing MCF-7
cells (pRSV-hPit-1), and Pit-1-overexpressing and knockdown of MMP-1 or MMP-13 MCF-7 cells (pRSV-hPit-1 + shMMP-1 or −13). e-f Cell motility
through matrigel-coated filters at 48 hours in control cells, cells transfected with the pRSV-hPit-1 vector, and cells transfected with pRSV-hPit-1 and
knockdown of MMP-1 (Pit-1 + shMMP-1) or MMP-13 (Pit-1 + shMMP-13). Numbers represent mean ± SD. Scale bar: 100 μm. MMP-1, matrix
metalloproteinase-1; MMP-13, matrix metalloproteinase-13; Pit-1, POU class 1 homeobox 1
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